Estrella Immunopharma, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted for 2021

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Estrella Immunopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate for 2021.
  • Estrella Immunopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 35.6M shares, a 10453% increase year-over-year.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 1.18M Jan 6, 2021 Dec 31, 2021 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.